Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities
Author:
Funder
National Institutes of Health
U.S. Department of Defense
Deutsche Forschungsgemeinschaft
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference478 articles.
1. Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy;Gilbert;Lancet,2015
2. Role of diabetes in congestive heart failure: the Framingham study;Kannel;Am. J. Cardiol.,1974
3. Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review;McHugh;J. Am. Coll. Cardiol.,2019
4. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme;MacDonald;Eur. Heart J.,2008
5. Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus;Aguilar;Am. J. Cardiol.,2010
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prognostic value of hibernating myocardium and cardiac remodeling using gated 99mTc-MIBI SPECT and gated 18F-FDG PET in patients with ischemic heart failure and diabetes;2024-02-01
2. Mendelian randomization provides evidence for a causal effect of serum insulin-like growth factor family concentration on risk of atrial fibrillation;World Journal of Clinical Cases;2023-12-26
3. Atorvastatin ameliorated myocardial fibrosis in db/db mice by inhibiting oxidative stress and modulating macrophage polarization;World Journal of Diabetes;2023-12-15
4. Diallyl trisulfide (DATS) ameliorates cardiac fibrosis in a rat model of diabetes;Journal of Functional Foods;2023-12
5. Ling-Gui-Qi-Hua formula alleviates left ventricular myocardial fibrosis in rats with heart failure with preserved ejection fraction by blocking the transforming growth factor-β1 /Smads signaling pathway;Journal of Ethnopharmacology;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3